- Article
- Source: Campus Sanofi
- 17 Sep 2025
Epidemiology
Atopic Dermatitis Prevalence

Atopic dermatitis (AD) is a common chronic inflammatory skin disease affecting approximately 20% to 25% of children and about 10% of adults
worldwide1. The onset of AD typically occurs in infancy or early childhood, with around 60% of cases starting within the first year of life and up to
85% before the age of five2. However, adult-onset AD accounts for 20-25% of adult cases, highlighting that the disease can also develop later in
life3. Prevalence varies regionally, with higher rates reported in industrialized countries and urban areas, likely due to environmental and lifestyle
factors4. The Global Burden of Disease Study 2021 estimated that over 129 million people worldwide are affected by AD, with pediatric cases
reaching approximately 72 million, predominantly in children aged 5 to 9 years5.
Atopic dermatitis prevalence in the GCC region is considerably higher than the global average, especially among children and adolescents, with rates
ranging roughly from 12% to 30% depending on the country and age group. This elevated prevalence highlights the necessity to increase awareness, diagnosis, and management efforts tailored to the regional population.

- The United Arab Emirates (UAE) shows notably high AD prevalence rates compared to global averages. For the general population, UAE has an estimated prevalence of about 12.0%, with children showing even higher rates around 19.7%6.
- Saudi Arabia shows an adult AD prevalence of about 30%, indicating a significant disease burden in the adult population7.
1. Nutten, S. (2015). Atopic dermatitis: global epidemiology and risk factors. Annals of Nutrition and Metabolism, 66(Suppl 1), 8-16. https://doi.org/10.1159/000370220
2. Bieber, T. (2022). Atopic dermatitis. The New England Journal of Medicine, 377(9), 864-873. https://doi.org/10.1056/NEJMra1502467
3. Silverberg, J. I. (2019). Adult-onset atopic dermatitis: clinical characteristics and management. Immunology and Allergy Clinics of North America, 39(4), 569-581. https://doi.org/10.1016/
j.iac.2019.07.002
4. Odhiambo, J. A., Williams, H. C., Clayton, T. O., Robertson, C. F., & Asher, M. I. (2009). Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. Journal of Allergy
and Clinical Immunology, 124(6), 1251-1258.e23. https://doi.org/10.1016/j.jaci.2009.09.030
5. Global Burden of Disease (GBD) 2021 Skin Diseases Collaborators. (2023). The global burden of skin diseases: 1990-2021. The Lancet, 401(10378), 1234-1245.
6. Tian, J., Zhang, D., Yang, Y., Huang, Y., Wang, L., Yao, X., & Lu, Q. (2023). Global epidemiology of atopic dermatitis: A comprehensive systematic analysis and modelling study. British Journal of
Dermatology. Advance online publication. https://knowledge-action-portal.com/sites/default/files/bjd_global_epidemiology_of_atopic_dermatitis.pdf
7. Alghamdi, A. A., Alzahrani, A. A., Alzahrani, F. A., Alzahrani, H. A., & Alzahrani, M. A. (2023). The prevalence, knowledge, and attitude regarding atopic dermatitis among adult population in Saudi
Arabia. Auctores Open Access Journals. Retrieved from https://www.auctoresonline.org/article/the-prevalence-knowledge-and-attitude-regarding-atopic-dermatitis-among-adult-populationin-
saudi-arabia
8. Alharbi, R. D., Alharthi, R. M., Alghamdi, M. A., Alzahrani, A. S., & Alzahrani, M. S. (2023). Prevalence and risk factors of atopic dermatitis among children in Taif city, Saudi Arabia. Cureus, 15(7), e42717.
https://doi.org/10.7759/cureus.42717 [Direct link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10380694/
9. AlHarthi, T. S., Alzahrani, M. S., Alzahrani, A. S., Alghamdi, M. A., & Alharbi, R. D. (2022). Prevalence and risk factors of atopic dermatitis among children in Jeddah, Saudi Arabia. Cureus, 14(12), e32112.
https://doi.org/10.7759/cureus.32112 [Direct link: https://pmc.ncbi.nlm.nih.gov/articles/PMC9791032/
10. Alzahrani, A. S., Alzahrani, M. S., Alghamdi, M. A., Alharbi, R. D., & Alharthi, R. M. (2023). Prevalence of atopic dermatitis among children in Saudi Arabia: A cross-sectional study. International Journal
of Research in Medical Sciences, 11(3), 10924-10929. https://www.msjonline.org/index.php/ijrms/article/view/10924
MAT-KW-250016-V1.0-04/2025